Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01602042 · ClinicalTrials.gov registry record

Adaptive Portable Essential Tremor Monitor

A clinical trial, sponsored by Great Lakes NeuroTechnologies.

Completed
Registry status
20
Enrollment target

NCT01602042 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01602042 has completed, sponsored by Great Lakes NeuroTechnologies.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-05
Est. Completion 2012-11

Sponsor

Great Lakes NeuroTechnologies

17 total trials

What the Registry Record Tells You About NCT01602042

The ClinicalTrials.gov registry entry for NCT01602042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Great Lakes NeuroTechnologies, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01602042 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01602042 about?

NCT01602042 is a clinical study titled "Adaptive Portable Essential Tremor Monitor". The purpose of this study is to evaluate the utility of a portable motion sensor-based system designed to monitor essential tremor (ET) to better prescribe therapy to minimize symptoms and expand care for ET patients.

What is the current status of trial NCT01602042?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2012-11.

Who is sponsoring clinical trial NCT01602042?

This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.